SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Taro Pharmaceutical Indus Q4 EPS $1.420 Misses $1.530 Estimate, Sales $174.900M Beat $168.240M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $1.420 per share which missed the analyst consensus estimate of $1.530 by 7.19 percent. This is a 6.58 percent decrease over earnings of $1.520 per

Benzinga · 05/19/2020 21:31

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $1.420 per share which missed the analyst consensus estimate of $1.530 by 7.19 percent. This is a 6.58 percent decrease over earnings of $1.520 per share from the same period last year. The company reported quarterly sales of $174.900 million which beat the analyst consensus estimate of $168.240 million by 3.96 percent. This is a 2.79 percent decrease over sales of $179.921 million the same period last year.